Women's health testing guide · 2026
The most common request during perimenopause is a hormone panel. The most useful tests are usually the ones that check what else could be causing the symptoms.
By MedEx · Updated September 2026 · Approx. 8-minute read
Quick answer
For most women over 45 with typical symptoms and a change in cycle pattern, menopause is a clinical diagnosis and hormone testing is not required. FSH fluctuates too widely during the transition to be reliable, and a normal result does not exclude perimenopause. Testing is appropriate under 45 where early menopause or primary ovarian insufficiency is suspected, and under 40 where the diagnosis carries significant implications. The tests that most often change management during this period are not hormones at all: thyroid function, ferritin, HbA1c, lipids and bone health assessment.
In this guide
- Why FSH is a poor perimenopause test
- When testing is appropriate
- The tests that change management most
- Testing on hormone therapy
| Over 45, typical symptoms | Clinical diagnosis; FSH testing not required |
|---|---|
| Under 45 | FSH on two occasions 4–6 weeks apart, with estradiol |
| Under 40 | Suspected primary ovarian insufficiency — specialist referral advised |
| Unreliable during | Combined hormonal contraception, which suppresses FSH |
| Most useful additions | TSH, free T4, ferritin, full blood count, HbA1c, lipids, vitamin D |
| Price | Listed on the MedEx lab test catalogue — same price nationwide |
Why FSH is a poor perimenopause test
During the transition, ovarian function does not decline smoothly — it fluctuates. FSH can be markedly raised one month and entirely normal the next, sometimes while symptoms are at their worst. A single sample therefore cannot confirm or exclude perimenopause.
Major guidance reflects this. In women over 45 with vasomotor symptoms and cycle change, the diagnosis is made clinically. Testing tends to add cost and confusion rather than clarity, and a normal FSH can lead to symptoms being dismissed.
Combined hormonal contraception suppresses FSH entirely, so testing during use tells you nothing about underlying ovarian function — a common source of misleading results in women using the pill into their late forties.
When testing is appropriate
- Under 45 with menopausal symptoms: FSH is reasonable, measured on two occasions 4 to 6 weeks apart, with estradiol.
- Under 40 with absent or infrequent periods: primary ovarian insufficiency should be considered. Two raised FSH results 4 to 6 weeks apart support the diagnosis, and specialist assessment is advised, including consideration of karyotype, fragile X premutation testing and autoimmune screening.
- Absent periods with an unclear cause at any age: pregnancy test, prolactin, TSH and free T4 come before FSH.
- Uncertainty after hysterectomy without oophorectomy: where cycle tracking is not possible, FSH may help.
Where primary ovarian insufficiency is confirmed, the implications extend well beyond symptoms — bone density, cardiovascular risk and fertility all need discussion, ideally through a specialist teleconsultation.
Rule out the mimics first — thyroid, iron, glucose and lipids in one draw.
The tests that change management most
Many perimenopausal symptoms overlap with conditions that are common, treatable and easy to miss:
| Fatigue, low mood, cold intolerance | TSH, free T4 — thyroid disease becomes more common with age |
|---|---|
| Fatigue, hair loss, breathlessness | Full blood count and ferritin — heavy perimenopausal bleeding frequently causes iron deficiency |
| Night sweats, weight change, thirst | HbA1c — glycaemic status often shifts in this decade |
| Cardiovascular risk reassessment | Lipid profile, blood pressure — risk rises after menopause |
| Bone health | Vitamin D, calcium; DEXA where risk factors are present |
This combination sits naturally inside a MedEx health checkup package and is usually more informative than a hormone panel at this stage of life.
Testing on hormone therapy
Routine hormone monitoring is not needed for most women on standard menopausal hormone therapy with good symptom control. The clinical response is the primary measure.
Serum estradiol can help in specific situations: transdermal or implanted oestrogen where symptoms are not controlled, suspected absorption problems, or unusually high doses. Testing FSH to titrate HRT is not useful.
What does warrant regular review is the broader risk picture — blood pressure, weight, lipids, glycaemic status, breast screening and bone health — alongside an annual discussion of whether the treatment is still doing what you want it to. Arrange that through a doctor consultation.
Frequently asked questions
Do I need a blood test to diagnose menopause?
Usually not. In women over 45 with typical symptoms and a change in cycle pattern, menopause is a clinical diagnosis and FSH testing is not required.
Why is FSH unreliable in perimenopause?
Ovarian function fluctuates rather than declining smoothly, so FSH can be markedly raised one month and normal the next. A single result can neither confirm nor exclude perimenopause.
When is menopause testing appropriate?
Under 45 with menopausal symptoms, using FSH on two occasions 4 to 6 weeks apart with estradiol. Under 40 with absent or infrequent periods, primary ovarian insufficiency should be considered and specialist assessment is advised.
Can I test FSH while taking the contraceptive pill?
No useful result will come from it. Combined hormonal contraception suppresses FSH, so it will not reflect your underlying ovarian function.
Which tests are most useful during the menopause transition?
Thyroid function, full blood count and ferritin, HbA1c, lipid profile and vitamin D. These identify common, treatable conditions that share symptoms with perimenopause.
Does HRT need blood test monitoring?
Not routinely when symptoms are well controlled. Serum estradiol can help with transdermal or implanted oestrogen where symptoms persist or absorption is in doubt. Using FSH to titrate HRT is not useful.
Symptoms under 45? That is when testing genuinely helps.
Sources and further reading
- NICE guideline NG23: Menopause — diagnosis and management
- MedEx health checkup packages
- MedEx lab test catalogue
Medical disclaimer: This article is general health information and does not replace medical advice, diagnosis or treatment. Laboratory reference ranges differ between laboratories and results must be interpreted alongside your symptoms, medicines and medical history. Speak with a qualified clinician before starting, stopping or changing any treatment. Service details, inclusions and prices can change — confirm them with MedEx before booking.


